ATOPIC DERMATITIS

This study tests a program that gives pregnant women personalized nutrition and lifestyle advice based on their genes and nutrient levels. The goal is to see if this approach can lower the chances of problems like preterm birth, preeclampsia, and gestational diabetes. About 500 p…

This phase 3 trial tests an injection called ADSTEM for adults with moderate to severe eczema (atopic dermatitis) that hasn't responded well to standard treatments. About 286 people aged 19 to 70 will receive either the study drug or a placebo. The main goal is to see if the inje…

This study compares two prescription creams—tacrolimus and crisaborole—for treating mild to moderate eczema in people aged 2 to 20 years. Both creams are steroid-free options that aim to control the skin condition without the side effects of long-term steroid use. Over 8 weeks, r…

This study tests a new medicine called MG-K10 for people aged 12 and older with moderate-to-severe atopic dermatitis (eczema) that hasn't improved with creams. About 498 participants will receive either MG-K10 or a placebo to see if it safely reduces skin redness, itching, and so…

This study tests whether removing Staphylococcus aureus bacteria from the skin can reduce eczema severity in 100 people aged 6 and older with moderate-to-severe atopic dermatitis. Participants will undergo a decolonization protocol, and researchers will measure changes in disease…

This study compares two steroid-free ointments—crisaborole and tacrolimus—for treating eczema in 148 Pakistani patients aged 2 and older. Both treatments aim to control symptoms like itching and redness without the side effects of steroids. Researchers will track skin improvement…

This study tests whether leaving the white, creamy coating (vernix caseosa) on a newborn's skin after birth can prevent eczema (atopic dermatitis) in the first year of life. About 1,383 babies will be randomly assigned to either keep the vernix or have it removed as usual. Resear…

This early-stage study tests a new drug called IBI3033 in 16 adults with moderate-to-severe atopic dermatitis (eczema). The main goal is to check if the drug is safe and tolerable, not to cure the disease. Participants will receive either the drug or a placebo over 12 weeks, with…

This study tests a cream called roflumilast for reducing itch in people with mild to moderate atopic dermatitis (eczema). About 40 participants aged 12 and older will use the cream daily for 4 weeks and report their itch and other skin sensations through a phone app. The goal is …

This study tests whether adding Urgo FilmoCream Eczema to standard steroid treatment helps relieve eczema symptoms better than steroids alone. About 44 adults with mild to moderate atopic dermatitis will have two similar eczema spots treated differently—one with steroids only, th…

This early-phase study tests a new drug called HXN5003 in 28 healthy adults to see if it is safe and how the body processes it. The drug is being developed for atopic dermatitis (eczema). Participants will receive either the drug or a placebo, and researchers will monitor for sid…

This study tests whether a new moisturizer made with a seawater ingredient works as well as a leading brand for treating mild to moderate eczema. About 86 children and adults will use one of two balms daily. The goal is to see if the new balm can match the standard treatment whil…

This study looks at whether cutting back on dietary salt can reduce the severity of eczema (atopic dermatitis). Forty adults will follow a low-salt diet for 24 weeks and take either sodium tablets or a placebo to see how salt intake affects their skin. Researchers will measure ec…

This study tests whether a newer cream (crisaborole) works as well as a standard cream (tacrolimus) for children aged 2–18 with mild to moderate eczema. About 66 kids will use one of the two creams twice daily for 28 days. The main goal is to see how many achieve clear or almost …

This early-stage study tests a new medicine called REGN20423 in healthy volunteers and people with atopic dermatitis (eczema). The main goals are to check safety, how the body processes the drug, and what dose might work best. About 136 adults will take part, and the study is not…

This study tests a grain-of-rice-sized microdevice that places tiny amounts of approved drugs directly into patches of psoriasis or eczema. The goal is to see if the device can safely predict how a person's skin will respond to standard treatments. Ten adults with these skin cond…

This study tests whether high-resolution eye images, analyzed by artificial intelligence, can help predict and classify inflammatory skin diseases like psoriasis and eczema. Researchers will enroll about 950 people, including patients and healthy volunteers, to build a model that…

This study will look at existing medical records from 20,000 people aged 12 and older in Italy who have psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa. Researchers want to learn about the types of treatments patients receive, how their diseas…

This early-stage study looks at how taking VC005 tablets with or without food changes the drug's levels in the blood. It involves 30 healthy adults aged 18 to 45. The results will help guide future dosing for atopic dermatitis (eczema) patients.

This study tests a new, gentle device that collects tiny fluid samples from babies' skin without needles. Researchers will compare healthy babies and those with eczema to find chemical signals linked to the condition. The goal is to better understand what causes eczema in infants…

This study will follow 50 Costa Rican adults with moderate-to-severe atopic dermatitis (eczema) who are already receiving advanced treatments like dupilumab or JAK inhibitors as part of their routine care. Researchers will collect data from regular doctor visits to see how sympto…

This study looks at how caring for a child with mild to moderate eczema (atopic dermatitis) affects caregivers' work and daily life. About 100 Canadian caregivers will answer questionnaires about lost work time and family impact. The goal is to gather real-world data to help doct…

This study aims to create a standard method for collecting and analyzing skin oil (sebum) to find biomarkers for skin diseases like acne, eczema, and psoriasis. Researchers will study 200 participants, including healthy people and those with skin conditions, to see how skin oil c…